ArticleComputational and structural biotechnology journal2026
Integrated metabolome and transcriptome analysis reveals ferroptosis involvement in cisplatin resistance of esophageal squamous cancer cell.
Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this study is to investigate the gene biomarkers and metabolites for esophageal squamous cell carcinoma (ESCC) or cisplatin (DDP)-resistance ESCC through integrated analysis of transcriptome and metabolome. A total of 6130 differentially expressed genes (DEGs) and 326 differentially expressed metabolites (DEMs) were identified in KYSE30 compared to HEEC, while compared to KYSE30, there were totally 1179 DEGs and 224 DEMs in KYSE30/DDP. Profile #6 depicted the mRNA characteristics of KYSE30 obviously. Genes in profile #6 were mainly involved in platinum drug resistance, ferroptosis, and glutathione metabolism. In addition, the associated TCGA dataset identified APOBEC3B as a critical gene involved in inhibiting ferroptosis by activating PD-L1 to suppress CD8
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.